Are there conditions where you would specifically favor using the subcutaneous over the IV formulation of pertuzumab/trastuzumab?
In which situations would you use subcutaneous trastuzumab + pertuzumab instead of an IV Infusion?
Join Mednetto vote and see how they answered.
With really long treatment programs like TCHP, utilizing SQ HP can really help cut down on infusion time, which is helpful as it allows a little more flexibility in booking the patients in the infusion center with regards to start times.
Join for free or sign in to see the full answer
Specific conditions I favor nclude, but not limited to the following:
1. Patient is receiving a non-IV containing regimen
2. Patient has limited peripheral access or no central access
3. Patient has a current central access that poses an infection risk or otherwise has an indication to be removed...
Join for free or sign in to see the full answer
Perhaps in a patient who is having problems with local reactions (not very common)
Join for free or sign in to see the full answer